Harrow (HROW) Research & Development (2010 - 2026)
Harrow (HROW) posted quarterly Research & Development of $5.9 million for Q1 2026, up 94.81% year-over-year from $3.0 million in Q1 2025, and down 49.71% quarter-over-quarter from $11.7 million in Q4 2025.
Harrow (HROW) Research & Development (2010 - 2026) Analysis & Trends
Harrow's Research & Development history runs 17 years deep, the most recent figure standing at $5.9 million for Q1 2026.
- In Q1 2026, Research & Development rose 94.81% year-over-year to $5.9 million; the TTM figure through Mar 2026 stood at $23.8 million (up 81.65% YoY), while the FY2025 annual figure was $20.9 million, up 71.22% from the prior year.
- Research & Development for Q1 2026 stood at $5.9 million, down from $11.7 million in the prior quarter.
- The five-year high for Research & Development was $11.7 million in Q4 2025, with the low at $658000.0 in Q1 2022.
- The 5-year median for Research & Development is $2.3 million (2024), against an average of $2.9 million.
- The sharpest annual moves came in 2022 and 2023: Research & Development slumped 87.35% in 2022, then jumped 374.54% in 2023.
- Harrow's Research & Development stood at $703000.0 in 2022, then jumped by 374.54% to $3.3 million in 2023, then surged by 42.54% to $4.8 million in 2024, then surged by 146.54% to $11.7 million in 2025, then plunged by 49.71% to $5.9 million in 2026.
- Business Quant data shows HROW's Research & Development at $5.9 million in Q1 2026, $11.7 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Harrow | 1.57 Bn | 1.49 Bn | 50.36 Mn | 8.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.07 Mn |
| Mar 31, 2026 | 5.90 Mn |
| Dec 31, 2025 | 11.72 Mn |
| Sep 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 3.34 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 734,000.00 |
| Dec 31, 2022 | 703,000.00 |
| Sep 30, 2022 | 775,000.00 |
| Jun 30, 2022 | 914,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 6.13 Mn |